K954607

Substantially Equivalent

RETICULOCYTE METHOD

Applicant: Bayer Corp.
Product code: GKL
Advisory panel: Hematology
Date received: 1995-10-04
Decision date: 1996-08-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.